Amiodarone Pulmonary Toxicity and Professor Hounsfield

Mason, Jay W.

doi:10.1046/j.1540-8167.2001.00437.x

Cited by 4 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, APT is characterized by alveolar, interstitial or mixed opacities on imaging [34, 60, 61, 62, 63]. The impression is that patients with APT all have distinct patterns of involvement on imaging, and it is easy to be misled.…”

Section: Clinical Patterns Of Di-ildmentioning

confidence: 99%

See 1 more Smart Citation

Interstitial Lung Disease Induced by Drugs and Radiation

Camus¹,

Fanton²,

Bonniaud³

et al. 2004

Respiration

350

273

View full text Add to dashboard Cite

An ever-increasing number of drugs can reproduce variegated patterns of naturally occurring interstitial lung disease (ILD), including most forms of interstitial pneumonias, alveolar involvement and, rarely, vasculitis. Drugs in one therapeutic class may collectively produce the same pattern of involvement. A few drugs can produce more than one pattern of ILD. The diagnosis of drug-induced ILD (DI-ILD) essentially rests on the temporal association between exposure to the drug and the development of pulmonary infiltrates. The histopathological features of DI-ILD are generally consistent, rather than suggestive or specific to the drug etiology. Thus, the diagnosis of DI-ILD is mainly made by the meticulous exclusion of all other possible causes. Drug dechallenge produces measurable improvement in symptoms and imaging in the majority of patients, whereas corticosteroid therapy is indicated if symptoms are present or drug dechallenge is without an effect. Rechallenge is justified in a minority of patients, and is discouraged for diagnostic purposes only. Pneumotox^® (www.pneumotox.com) provides updated information on drug-induced respiratory disease.

show abstract

Section: Clinical Patterns Of Di-ildmentioning

confidence: 99%

“…High density in the area of APT was present in 8 of the 20 patients. In advanced disease, increased attenuation seems a consistent feature of APT [60]. An exudative pleural effusion is occasionally present in association with parenchymal disease [53].…”

Section: Clinical Patterns Of Di-ildmentioning

confidence: 99%

Interstitial Lung Disease Induced by Drugs and Radiation

Camus¹,

Fanton²,

Bonniaud³

et al. 2004

Respiration

350

273

View full text Add to dashboard Cite

show abstract

Current Awareness

2001

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Drug-Induced Respiratory Disease in Cardiac Patients

Camus

Foucher

2009

Integrated Cardiothoracic Imaging With MDCT

View full text Add to dashboard Cite

Amiodarone Pulmonary Toxicity and Professor Hounsfield

Cited by 4 publications

References 2 publications

Interstitial Lung Disease Induced by Drugs and Radiation

Interstitial Lung Disease Induced by Drugs and Radiation

Current Awareness

Drug-Induced Respiratory Disease in Cardiac Patients

Contact Info

Product

Resources

About